DYSPNOEA is the #5 most commonly reported adverse reaction for ANTACID, manufactured by CVS Pharmacy. There are 3,708 FDA adverse event reports linking ANTACID to DYSPNOEA. This represents approximately 2.0% of all 184,150 adverse event reports for this drug.
Patients taking ANTACID who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DYSPNOEA3,708 of 184,150 reports
DYSPNOEA is a less commonly reported adverse event for ANTACID, but still significant enough to appear in the safety profile.
Other Side Effects of ANTACID
In addition to dyspnoea, the following adverse reactions have been reported for ANTACID:
DYSPNOEA has been reported as an adverse event in 3,708 FDA reports for ANTACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DYSPNOEA with ANTACID?
DYSPNOEA accounts for approximately 2.0% of all adverse event reports for ANTACID, making it a notable side effect.
What should I do if I experience DYSPNOEA while taking ANTACID?
If you experience dyspnoea while taking ANTACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.